(Q37352039)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Pregnancy in Parkinson's disease: case report and discussion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Bradley J Robottom

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lisa M Shulman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1799-1805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19086876%20AND%20SRC:MED&resulttype=core&format=json

The effect of pregnancy in Parkinson's disease.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Pramipexole-treated Parkinson's disease during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Selegiline, pregnancy, and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Pregnancy in Parkinson's disease: a review of the literature and a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Antiparkinsonian treatment in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Gender ratio differences between Parkinson's disease patients and their affected relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Functional decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Gender differences in Parkinson's disease symptom profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Body weight influences pharmacokinetics of levodopa in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Clinical pharmacokinetics of ropinirole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Frequency, reasons, and risk factors of entacapone discontinuation in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Inhibition of striatal dopamine transporter activity by 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799

Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.12.1799